Walleye Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-262,481
| Closed | -$593K | – | 2722 |
|
|
2023
Q1 | $593K | Sell |
262,481
-211,202
| -45% | -$477K | 0.01% | 931 |
|
|
2022
Q4 | $1.65M | Buy |
+473,683
| New | +$1.65M | 0.03% | 531 |
|
|
2022
Q3 | – | Sell |
-106,420
| Closed | -$2.02M | – | 2674 |
|
|
2022
Q2 | $2.02M | Sell |
106,420
-16,809
| -14% | -$319K | 0.06% | 354 |
|
|
2022
Q1 | $3.33M | Buy |
123,229
+102,410
| +492% | +$2.76M | 0.09% | 224 |
|
|
2021
Q4 | $469K | Buy |
+20,819
| New | +$469K | 0.01% | 1003 |
|